Status:
COMPLETED
Autologous Chondrocyte Intra-articular Implantation in Patients With Severe Hip Osteoarthritis
Lead Sponsor:
Royan Institute
Conditions:
Hip Osteoarthritis
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
Hip osteoarthritis is degeneration of hip cartilage and inflammation of subchondral bone and soft tissue linings. Patients have pain, stiffness, swelling, and difficulty walking. There are treatments ...
Detailed Description
In this phase I clinical study 6 patients with severe hip osteoarthritis will be recruited. All patients will have a cartilage biopsy taken from the knee cartilage non-weight bearing zone. Chodrocytes...
Eligibility Criteria
Inclusion
- Osteoarthritis diagnosed by MRI
Exclusion
- Pregnancy or lactating
- Positive tests for HIV, HCV, HBV
- Active neurologic disorder
- End organ damage
- Uncontrolled endocrine disorder.
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01500811
Start Date
March 1 2011
End Date
August 1 2013
Last Update
April 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royan Institute
Tehran, Iran